Regeneron Pharmaceuticals' Other Operating Expenses rose 22500.0% to $10.0 million in Q3 2025 from the same period last year, while for Dec 2025 it was $10.0 million, marking a year-over-year increase of 11872.66%. This contributed to the annual value of $10.0 million for FY2025, which is 11872.66% up from last year.
Per Regeneron Pharmaceuticals' latest filing, its Other Operating Expenses stood at $10.0 million for Q3 2025, which was up 22500.0% from -$15.5 million recorded in Q4 2024.
Over the past 5 years, Regeneron Pharmaceuticals' Other Operating Expenses peaked at $45.7 million during Q3 2022, and registered a low of -$42.0 million during Q3 2021.
Over the past 5 years, Regeneron Pharmaceuticals' median Other Operating Expenses value was $600000.0 (recorded in 2023), while the average stood at $5.5 million.
Per our database at Business Quant, Regeneron Pharmaceuticals' Other Operating Expenses tumbled by 320000.0% in 2024 and then surged by 22500.0% in 2025.
Regeneron Pharmaceuticals' Other Operating Expenses (Quarter) stood at $15.8 million in 2021, then plummeted by 58.23% to $6.6 million in 2022, then crashed by 92.42% to $500000.0 in 2023, then tumbled by 3200.0% to -$15.5 million in 2024, then surged by 164.52% to $10.0 million in 2025.
Its Other Operating Expenses stands at $10.0 million for Q3 2025, versus -$15.5 million for Q4 2024 and -$8.0 million for Q3 2024.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value